ME Therapeutics Holdings Inc. (CSE:METX)
Canada
· Delayed Price · Currency is CAD 3.990
+1.000 (33.44%)
At close: Dec 2, 2025
ME Therapeutics Holdings Balance Sheet
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | 2020 |
| Cash & Equivalents | 1.35 | 1.5 | 0.65 | 0.08 | 0.07 | Upgrade
|
| Short-Term Investments | 0.06 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 1.4 | 1.5 | 0.65 | 0.08 | 0.07 | Upgrade
|
| Cash Growth | -6.27% | 131.28% | 736.35% | 5.91% | 47.00% | Upgrade
|
| Other Receivables | 0.07 | 0.02 | 0.01 | 0.02 | 0 | Upgrade
|
| Receivables | 0.07 | 0.02 | 0.01 | 0.02 | 0 | Upgrade
|
| Prepaid Expenses | 0.03 | 0.03 | 0.02 | 0 | - | Upgrade
|
| Total Current Assets | 1.5 | 1.54 | 0.67 | 0.1 | 0.08 | Upgrade
|
| Property, Plant & Equipment | 0.25 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Long-Term Assets | 0.01 | - | - | - | - | Upgrade
|
| Total Assets | 1.76 | 1.54 | 0.67 | 0.1 | 0.08 | Upgrade
|
| Accounts Payable | 0.16 | 0.05 | 0.11 | 0.02 | 0.03 | Upgrade
|
| Accrued Expenses | 0.01 | 0.02 | - | - | - | Upgrade
|
| Short-Term Debt | - | - | - | 0.13 | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 0.04 | - | - | Upgrade
|
| Current Portion of Leases | 0.06 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 0.01 | - | 0 | 0.02 | 0.01 | Upgrade
|
| Total Current Liabilities | 0.25 | 0.06 | 0.15 | 0.17 | 0.03 | Upgrade
|
| Long-Term Debt | - | - | - | 0.06 | 0.06 | Upgrade
|
| Long-Term Leases | 0.01 | - | - | - | - | Upgrade
|
| Total Liabilities | 0.26 | 0.06 | 0.15 | 0.23 | 0.09 | Upgrade
|
| Common Stock | 8.59 | 6.11 | 4.52 | 0.51 | 0.51 | Upgrade
|
| Retained Earnings | -9.73 | -8.54 | -7.24 | -0.72 | -0.57 | Upgrade
|
| Comprehensive Income & Other | 2.64 | 3.9 | 3.24 | 0.08 | 0.04 | Upgrade
|
| Shareholders' Equity | 1.5 | 1.48 | 0.52 | -0.13 | -0.02 | Upgrade
|
| Total Liabilities & Equity | 1.76 | 1.54 | 0.67 | 0.1 | 0.08 | Upgrade
|
| Total Debt | 0.07 | - | 0.04 | 0.19 | 0.06 | Upgrade
|
| Net Cash (Debt) | 1.33 | 1.5 | 0.61 | -0.12 | 0.01 | Upgrade
|
| Net Cash Growth | -11.06% | 146.52% | - | - | 34.62% | Upgrade
|
| Net Cash Per Share | 0.05 | 0.06 | 0.04 | -0.01 | 0.00 | Upgrade
|
| Filing Date Shares Outstanding | 30.05 | 25.19 | 23.56 | 6.08 | 6.08 | Upgrade
|
| Total Common Shares Outstanding | 29.59 | 25.19 | 23.56 | 6.08 | 6.08 | Upgrade
|
| Working Capital | 1.26 | 1.48 | 0.52 | -0.07 | 0.04 | Upgrade
|
| Book Value Per Share | 0.05 | 0.06 | 0.02 | -0.02 | -0.00 | Upgrade
|
| Tangible Book Value | 1.5 | 1.48 | 0.52 | -0.13 | -0.02 | Upgrade
|
| Tangible Book Value Per Share | 0.05 | 0.06 | 0.02 | -0.02 | -0.00 | Upgrade
|
| Machinery | 0.19 | 0 | 0 | 0 | 0 | Upgrade
|
| Leasehold Improvements | 0.03 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.